This page lists the SEC filings reported by RA Capital Management.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2013-03-04 | RA CAPITAL MANAGEMENT, LLC | HYPERION THERAPEUTICS INC | 866,088 | 5.2% | EDGAR |
| SC 13G | 2013-02-15 | RA CAPITAL MANAGEMENT, LLC | MELA SCIENCES, INC. /NY | 2,992,608 | 7.9% | EDGAR |
| SC 13G | 2013-02-15 | RA CAPITAL MANAGEMENT, LLC | KERYX BIOPHARMACEUTICALS INC | 5,285,000 | 6.5% | EDGAR |
| SC 13G | 2013-02-15 | RA CAPITAL MANAGEMENT, LLC | NEWLINK GENETICS CORP | 1,576,981 | 6.2% | EDGAR |
| SC 13G/A | 2013-02-14 | RA CAPITAL MANAGEMENT, LLC | GENTA INC DE/ | 662,117,262 | 9.9% | EDGAR |
| SC 13G/A | 2013-02-14 | RA CAPITAL MANAGEMENT, LLC | ACADIA PHARMACEUTICALS INC | 7,347,878 | 9.3% | EDGAR |
| SC 13G/A | 2013-02-14 | RA CAPITAL MANAGEMENT, LLC | Vanda Pharmaceuticals Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2013-02-14 | RA CAPITAL MANAGEMENT, LLC | VENTRUS BIOSCIENCES INC | 628,092 | 3.4% | EDGAR |
| SC 13G/A | 2013-02-14 | RA CAPITAL MANAGEMENT, LLC | Anacor Pharmaceuticals Inc | 0 | 0.0% | EDGAR |
| SC 13G/A | 2013-02-14 | RA CAPITAL MANAGEMENT, LLC | XOMA Corp | 6,698,558 | 8.2% | EDGAR |
| SC 13G/A | 2013-02-14 | RA CAPITAL MANAGEMENT, LLC | Anthera Pharmaceuticals Inc | 0 | 0.0% | EDGAR |
| SC 13G/A | 2013-02-14 | RA CAPITAL MANAGEMENT, LLC | BIOCRYST PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2013-02-14 | RA CAPITAL MANAGEMENT, LLC | CORONADO BIOSCIENCES INC | 1,735,597 | 7.1% | EDGAR |
| SC 13G/A | 2013-02-14 | RA CAPITAL MANAGEMENT, LLC | DERMA SCIENCES, INC. | 1,599,332 | 10.0% | EDGAR |
| SC 13G/A | 2013-02-14 | RA CAPITAL MANAGEMENT, LLC | DYAX CORP | 8,528,440 | 8.6% | EDGAR |
| SC 13G/A | 2013-02-14 | RA CAPITAL MANAGEMENT, LLC | ENDOCYTE INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2013-02-14 | RA CAPITAL MANAGEMENT, LLC | INSMED INC | 2,433,319 | 7.0% | EDGAR |
| SC 13G/A | 2013-02-14 | RA CAPITAL MANAGEMENT, LLC | MEI Pharma, Inc. | 991,666 | 6.6% | EDGAR |
| SC 13G/A | 2013-02-14 | RA CAPITAL MANAGEMENT, LLC | NOVAVAX INC | 14,411,748 | 9.7% | EDGAR |
| SC 13G/A | 2013-02-14 | RA CAPITAL MANAGEMENT, LLC | ONCOGENEX PHARMACEUTICALS, INC. | 894,232 | 6.1% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.